Pàgina inicial > Resultats de la cerca: Morton, J.
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 5 registres trobats en 0.02 segons.
Articles, 5 registres trobats
Articles 5 registres trobats  
1.
9 p, 765.8 KB Mortality trends in type 1 diabetes : a multicountry analysis of six population-based cohorts / Ruiz, P.L.D. (Diabetes and Population Health. Baker Heart and Diabetes Institute) ; Chen, Lei (Baker Heart and Diabetes Institute) ; Morton, J.I. (Monash University) ; Salim, A. (The University of Melbourne) ; Carstensen, B. (Steno Diabetes Center Copenhagen) ; Gregg, E.W. (Imperial College London) ; Pavkov, M.E. (Centers for Diseases Control and Prevention) ; Mata-Cases, Manel (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ; Nichols, G.A. (Kaiser Permanente Center for Health Research) ; Pildava, S. (Centre for Disease Prevention and Control) ; Read, S.H. (University of Edinburgh) ; Wild, S.H. (University of Edinburgh) ; Shaw, J.E. (La Trobe University) ; Magliano, D.J. (Monash University) ; Universitat Autònoma de Barcelona
Mortality has declined in people with type 1 diabetes in recent decades. We examined how the pattern of decline differs by country, age and sex, and how mortality trends in type 1 diabetes relate to trends in general population mortality. [...]
2022 - 10.1007/s00125-022-05659-9
Diabetologia, Vol. 65 Núm. 6 (june 2022) , p. 964-972  
Registre complet - Creative Commons
2.
10 p, 667.7 KB Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma : a cytogenetic subgroup analysis of POLLUX / Kaufman, J. L. (Winship Cancer Institute. Emory University) ; Dimopoulos, Meletios (The National and Kapodistrian University of Athens) ; White, D. (Dalhousie University and Queen Elizabeth II Health Sciences Centre) ; Benboubker, L. (Service d'Hématologie et Thérapie Cellulaire. Hôpital Bretonneau. Centre Hospitalier Régional Universitaire) ; Cook, G. (St James's Institute of Oncology. Leeds Teaching Hospitals National Health Service Trust and University of Leeds) ; Leiba, M. (Assuta Ashdod University Hospital. Faculty of Health Science Ben-Gurion University of the Negev) ; Morton, J. (Icon Cancer Care) ; Joy Ho, P. (Institute of Haematology. Royal Prince Alfred Hospital) ; Kim, K. (Department of Medicine. Samsung Medical Center. Sungkyunkwan University School of Medicine) ; Takezako, N. (Department of Hematology. National Hospital Organization Disaster Medical Center of Japan) ; Moreau, Philippe (Hematology. University Hospital Hôtel-Dieu) ; Sutherland, H. J. (Leukemia/Bone Marrow Transplant Program. University of British Columbia) ; Magen, H. (Department of Hematology Chaim Sheba Medical Center. Ramat-Gan. Sackler Faculty of Medicine. Tel Aviv University) ; Iida, S. (Department of Hematology and Oncology. Nagoya City University Graduate School of Medical Sciences) ; Kim, J. S. (Yonsei University College of Medicine. Severance Hospital) ; Miles Prince, H. (Cabrini Hospital. Epworth HealthCare and Sir Peter MacCallum Department of Oncology. University of Melbourne) ; Cochrane, T. (Gold Coast University Hospital and Griffiths University) ; Oriol, Albert (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Bahlis, N. J. (University of Calgary. Arnie Charbonneau Cancer Institute) ; Chari, Ajai (Icahn School of Medicine at Mount Sinai) ; O'Rourke, L. (Janssen Research & Development) ; Trivedi, S. (Janssen Research & Development) ; Casneuf, T. (Janssen Research & Development) ; Krevvata, M. (Janssen Research & Development) ; Ukropec, J. (Janssen Global Medical Affairs) ; Kobos, R. (Janssen Research & Development) ; Avet-Loiseau, Hervé (Unite de Genomique du Myelome. IUC-Oncopole) ; Usmani, S. Z. (Levine Cancer Institute/Atrium Health) ; San-Miguel, J. (Clínica Universidad de Navarra. Centro de Investigación Médica Aplicada) ; Universitat Autònoma de Barcelona
High cytogenetic risk abnormalities confer poor outcomes in multiple myeloma patients. In POLLUX, daratumumab/lenalidomide/dexamethasone (D-Rd) demonstrated significant clinical benefit versus lenalidomide/dexamethasone (Rd) in relapsed/refractory multiple myeloma (RRMM) patients. [...]
2020 - 10.1038/s41408-020-00375-2
Blood Cancer Journal, Vol. 10 Núm. 11 (january 2020) , p. 111  
Registre complet - Creative Commons
3.
13 p, 819.4 KB Microbial Reduction of Fe(III) in the Fifthian and Muloorina illites : Contrasting extents and rates of bioreduction / Seabaugh, Jennifer L. (Miami University. Department of Geology) ; Dong, Hailiang (Miami University. Department of Geology) ; Kukkadapu, Ravi K. (Pacific Northwest National Laboratory) ; Eberl, Dennis D. (United States Geological Survey) ; Morton, John P. (Miami University. Department of Geology) ; Kim, Jinwook (Seafloor Sciences Branch. Naval Research Laboratory)
Shewanella putrefaciens CN32 reduces Fe(III) within two illites which have different properties: the Fithian bulk fraction and the <0. 2 μm fraction of Muloorina. The Fithian illite contained 4. [...]
2006 - 10.1346/CCMN.2006.0540109
Clays and Clay Minerals, Vol. 54, Núm. 1 (2006) , p. 67-79  
Registre complet -
4.
15 p, 252.9 KB Partitioning of Fe(II) in reduced nontronite (NAu-2) to reactive sites : Reactivity in terms of Tc(VII) reduction / Jaisi, Deb P. (Yale University. Department of Geology and Geophysics) ; Dong, Hailiang (Miami University. Department of Geology) ; Morton, John P. (Miami University. Department of Geology)
Clay minerals impart important chemical properties to soils, in part, by virtue of changes in the redox state of Fe in their crystal structures. Therefore, measurement of Fe(III)/Fe(II) and partitioning of Fe(II) in different reactive sites in clay minerals (during biological and chemical Fe(III) reduction) is essential to understand their role and their relative reactivity in terms of reduction and immobilization of heavy metal contaminants such as technetium. [...]
2008 - 10.1346/CCMN.2008.0560204
Clays and Clay Minerals, Vol. 56, Núm. 2 (2008) , p. 175-189  
Registre complet -
5.
12 p, 1.3 MB Nontronite particle aggregation induced by microbial Fe(III) reduction and exopolysaccharide production / Jaisi, Deb P. (Miami University. Department of Geology) ; Dong, Hailiang (Miami University. Department of Geology) ; Kim, Jinwook (Naval Research Laboratory) ; He, Ziqi (The Ohio State University. Department of Civil and Environmental Engineering and Geodetic Science) ; Morton, John P. (Miami University. Department of Geology)
Clay particle aggregation affects a number of environmental processes, such as contaminant sorption/desorption, particle movement/deposition, and sediment structure and stability, yet factors that control clay aggregation are not well understood. [...]
2007 - 10.1346/CCMN.2007.0550108
Clays and Clay Minerals, Vol. 55, Núm. 1 (2007) , p. 96-107  
Registre complet -

Vegeu també: autors amb noms similars
1 Morton, J.I.
3 Morton, John P.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem